Media Contact:
Michelle Murray
Chief Marketing Officer
Phone: 212.701.3614
Fax: 212.378.2410

Legal News

Cahill Represents Lead Arrangers in connection with a $2.675 Billion Refinancing of Ortho-Clinical Diagnostics’ existing Credit Facilities

Date: 06/08/18

Cahill represented the lead arrangers in connection with an amended $2,325,000,000 Term B credit facility and an amended $350,000,000 revolving credit facility for Ortho-Clinical Diagnostics S.A. and Ortho-Clinical Diagnostics, Inc.  Ortho-Clinical Diagnostics is a global provider of in vitro diagnostics providing high-quality products and services to the global clinical laboratory and immunohematology communities. Proceeds from the amended facilities were used on the amendment effective date to refinance existing indebtedness, and proceeds from the revolving credit facility may be used in the future for general corporate purposes.